Sign up for free insights newsletter
GN

Getinge Industrier AB

GNGBYUnited States

Need professional-grade analysis? Visit stockanalysis.com

$19.44
+2.37%
End of day
Market Cap

$5.43B

P/E Ratio

22.24

Employees

11,670

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.14-2.06-1.88-1.07-0.47-0.18-0.92
Calmar-12.78-4.66-2.20-1.02-0.48-0.08-1.78
Sharpe-0.67-1.87-1.61-0.85-0.35-0.14-0.75
Omega0.710.450.660.860.961.010.84
Martin-21.09-9.04-5.16-3.11-1.30-0.11-3.70
Ulcer2.048.349.777.528.4950.1418.56

Getinge Industrier AB (GNGBY) Price Performance

Getinge Industrier AB (GNGBY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $19.44, up 2.37% from the previous close.

Over the past year, GNGBY has traded between a low of $17.39 and a high of $24.62. The stock has lost 9.8% over this period. It is currently 21.0% below its 52-week high.

Getinge Industrier AB has a market capitalization of $5.43B, with a price-to-earnings ratio of 22.24.

About Getinge Industrier AB

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$35.85B
EBITDA
$5.48B
Profit Margin
6.46%
EPS (TTM)
0.89
Book Value
107.11

Technical Indicators

52 Week High
$24.67
52 Week Low
$17.39
50 Day MA
$22.54
200 Day MA
$21.76
Beta
0.88

Valuation

Trailing P/E
22.24
Forward P/E
14.68
Price/Sales
1.43
Price/Book
1.70
Enterprise Value
$6.30B